Fresenius stock: Forecast for 2024 with ups and downs
The Fresenius share has risen significantly at the start of trading after the presentation of the figures for 2023, including the outlook for the current year, and is now trading about 4 percent higher. With a price of around 27 euros, the stock is now approaching the previously contested mark of 30 euros, which has been fought for several times in 2023 (as of February 21, 2024, approximately 9:30 a.m.).
However, the DAX company was not able to fully convince with its forecast for 2024: the planned revenue growth fell short of expectations. However, the completion of the 2023 fiscal year and the EBIT forecast for the current year are both positive. Fresenius wants to focus on „progress in financial development“ – in the long term, this is certainly not bad news for investors.
Fresenius with fresh figures and outlook After a solid final quarter, Fresenius presented the figures for the full year. In 2023, the company generated around 22.3 billion euros in revenue, an increase of 6 percent compared to the previous year on a currency-adjusted basis. EBIT also rose by 3 percent on a currency-adjusted basis to just under 2.3 billion euros.
As the stock market is known to trade in the future, the focus is primarily on the forecast for the current year. And here, Fresenius has not exactly caused enthusiasm with a planned organic revenue growth between 3 and 6 percent. However, on the earnings side, things are already looking better: on a currency-adjusted basis, the DAX company wants to increase EBIT in 2024 by 4 to 8 percent compared to the previous year.
Fresenius share: Profit growth as the core goal The company emphasized that it has set itself the goal of accelerated profit growth for 2024. This is to be achieved through measures such as debt reduction or cost savings and is also reflected in the EBIT forecast. Long-term oriented investors will like the plan with improved profitability.
Accordingly, the Fresenius share also reacted positively after a brief period of skepticism due to the revenue targets and jumped up. According to the press release, the company has „set decisive course for Fresenius and got it back on track“ in 2023. Many analysts and investors share this view and are optimistic about the Fresenius share – although the prices from 2016 to 2018, with quotations sometimes above 70 euros, are still far from being within reach.
Source: https://aktienscreener.com